Incyte BioSciences France
1 clinical trials · Sponsor
◉ Watch Incyte BioSciences France
| Record | Firm | Date |
|---|---|---|
| Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®) (NCT04048564) | Incyte BioSciences France | 2018-02-23 |
Track Incyte BioSciences France automatically
Every clearance here is in the API, with alerts when new ones post.